Not Signed In -
Ciprofloxacin tablets |
Cipro |
Ciprofloxacin Systematic (IUPAC) name 1-cyclopropyl-6-fluoro-4-oxo- 7-piperazin-1-yl-quinoline-3-carboxylic acid Identifiers CAS number 85721-33-1 ATC code J01MA02 S01AX13 S03AA07 PubChem 2764 DrugBank APRD00424 Chemical data Formula C17H18FN3O3 Mol. weight 331.346 Pharmacokinetic data Bioavailability 69%[1] Metabolism Hepatic, including CYP1A2 Half life 4 hours Excretion Renal Therapeutic considerations Pregnancy cat. B3 (Australia), C (USA) Lega ...
Wikipedia - [full article]
Ciprofloxacin tablets Clinical Trials
- Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00003824 - Active, not recruiting
transitional cell carcinoma of the bladder; stage 0 bladder cancer; recurrent bladder cancer
- Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
Pain
- Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
ClinicalTrials.gov Identifier: NCT00062231 - Active, not recruiting
adult solid tumor; fever, sweats, and hot flashes; hematopoietic and lymphoid cancer; Infection; Neutropenia
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
Parkinson's Disease
- Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial
ClinicalTrials.gov Identifier: NCT00142272 - Completed
Cholera
- Cefpodoxime vs Ciprofloxacin for Acute Cystitis
ClinicalTrials.gov Identifier: NCT00194532 - Recruiting
Urinary Tract Infection
- Sub-Tenon’s Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery
ClinicalTrials.gov Identifier: NCT00431028 - Recruiting
Inflammation; Bacterial Infections
- Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aerug
ClinicalTrials.gov Identifier: NCT00481689 - Completed
Urinary Tract Infections
- Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
Pain
- RCT Comparing CPFX and CFPM in Febrile Neutropenic Patients with Hematologic Diseases
ClinicalTrials.gov Identifier: NCT00137787 - Recruiting
Febrile Neutropenia
- VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Prior Therapy
ClinicalTrials.gov Identifier: NCT00004216 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
Analgesia
- Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
Allergy
- Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
Transplantation; Kidney Transplantation; Immunosuppression
- Long-Term Administration Study of SND 919 Tablets in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00274131 - Active, not recruiting
Parkinson Disease
- Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
Allergy
- Study of Antibiotics in the Treatment of Colonic Crohn''s Disease
ClinicalTrials.gov Identifier: NCT00257699 - Recruiting
Crohn''s Disease
- A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
Schizophrenia; Psychotic Disorders
- A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
Analgesics, Opioid.; Pain
- Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
Chronic Hepatitis B
- A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
Schizophrenia
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
Epilepsy, Partial
- Low-risk Fever and Neutropenia in Children with Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting
ClinicalTrials.gov Identifier: NCT00107081 - Recruiting
Fever; Neutropenia; Cancer
- Lopinavir Capsules to Kaletra or Invirase Tablets
ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
HIV Infections
- Early Pseudomonas Infection Control (EPIC) Trial
ClinicalTrials.gov Identifier: NCT00097773 - Recruiting
Cystic Fibrosis; Infection; Lung Diseases
- Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
Essential Hypertension
- A MULTICENTER, OPEN-LABEL, RANDOMIZED CROSSOVER TRIAL TO ASSESS SUBJECT PREFERENCE FOR ALPRAZOLAM ORALLY DISINTEGRATING TABLETS COMPARED TO CONVENTIONAL ALPRAZOLAM TABLETS IN SUBJECTS WITH ANXIETY
ClinicalTrials.gov Identifier: NCT00139854 - Completed
Anxiety
- Standard Vs. Biofilm Susceptibility Testing in CF
ClinicalTrials.gov Identifier: NCT00153634 - Recruiting
Cystic Fibrosis; Chronic Bronchitis
- Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
Allergy
- A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
Attention Deficit Hyperactivity Disorder
- Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
Allergy
- Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
Onychomycosis of the Toenail
- Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
ClinicalTrials.gov Identifier: NCT00463047 - Recruiting
Chronic Pain
- Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
ClinicalTrials.gov Identifier: NCT00541385 - Recruiting
Malaria
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
Alzheimer Disease
- An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
Schizophrenia; Bipolar Disorder
- Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
Seasonal Allergic Rhinoconjunctivitis
- Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
Chronic Idiopathic Thrombocytopenic Purpura (ITP)
- Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
Chronic Lymphocytic Leukemia
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141557 - Recruiting
Menopause
- A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
HIV Infection
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
Alzheimer's Disease
- Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
Alzheimer's Disease
- A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00358917 - Recruiting
HIV Infection
- Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00002850 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141544 - Recruiting
Menopause
- Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
ClinicalTrials.gov Identifier: NCT00263575 - Recruiting
Pain; Cancer
- A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium avium Infection in HIV-Infected Individuals.
ClinicalTrials.gov Identifier: NCT00000641 - Completed
Mycobacterium avium-intracellulare Infection; HIV Infections
- Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
ClinicalTrials.gov Identifier: NCT00262678 - Recruiting
Pain; Cancer
- Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
ClinicalTrials.gov Identifier: NCT00543426 - Recruiting
Posthepatitic Cirrhosis
- Post Marketing Surveillance Study to Observe Safety and Efficacy of Champix® Tablets
ClinicalTrials.gov Identifier: NCT00483002 - Not yet recruiting
Smoking Cessation
- Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn''s Disease
ClinicalTrials.gov Identifier: NCT00130390 - Recruiting
Crohn''s Disease
- Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
ClinicalTrials.gov Identifier: NCT00305071 - Not yet recruiting
Pyuria; Urinary Tract Infections
- Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov Identifier: NCT00280631 - Recruiting
Myelodysplastic Syndrome (MDS)
- Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease
ClinicalTrials.gov Identifier: NCT00367913 - Completed
Pulmonary Diseases
- Effects of Cranberry-Containing Products in Women with Recurrent Urinary Tract Infections (UTIs)
ClinicalTrials.gov Identifier: NCT00100061 - Recruiting
Urinary Tract Infection
- A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial Prostatitis
ClinicalTrials.gov Identifier: NCT00236808 - Completed
Prostatitis
- A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
Restless Legs Syndrome
- Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
Parkinson's Disease
- Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
ClinicalTrials.gov Identifier: NCT00313105 - Not yet recruiting
Tobacco Dependence
- Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
ClinicalTrials.gov Identifier: NCT00556894 - Not yet recruiting
Rheumatoid Arthritis
- A Multicenter, Open-Label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects with Stable Parkinson''s Disease
ClinicalTrials.gov Identifier: NCT00139867 - Completed
Parkinson''s Disease
- Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
Epilepsy
- Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
Restless Legs Syndrome
- A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin
ClinicalTrials.gov Identifier: NCT00257062 - Completed
Skin Diseases, Infectious
- A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.
ClinicalTrials.gov Identifier: NCT00210886 - Completed
Urinary Tract Infections; Pyelonephritis
- A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin
ClinicalTrials.gov Identifier: NCT00257036 - Completed
Skin Diseases, Infectious; Cellulitis
- Monoclonal Antibody for Treatment of Inhalation Anthrax
ClinicalTrials.gov Identifier: NCT00138411 - Completed
Bacillus anthracis (anthrax)
- Prophylactic Antibiotics on Urethral Catheter Withdrawal
ClinicalTrials.gov Identifier: NCT00126698 - Completed
Urinary Tract Infection; Bacteriuria
- A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections
ClinicalTrials.gov Identifier: NCT00258089 - Completed
Pyelonephritis; Neurogenic Bladder; Bacteriuria; Urologic Diseases; Urinary Tract Infections
- Intravenous azithromycin plus intravenous ceftriaxone followed by oral azithromycin with intravenous levofloxacin followed by oral levofloxacin for the treatment of moderate to severely ill hospitalized patients with community acquired pneumonia.
ClinicalTrials.gov Identifier: NCT00035347 - Completed
Pneumonia
- Mefloquine Bioequivalence Among 3 Commercially Available Tablets.
ClinicalTrials.gov Identifier: NCT00544024 - Completed
Malaria
- Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
ClinicalTrials.gov Identifier: NCT00062556 - Completed
Intermittent Claudication; Peripheral Vascular Disease
- Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal Flora
ClinicalTrials.gov Identifier: NCT00190151 - Terminated
Healthy Volunteers
- Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
ClinicalTrials.gov Identifier: NCT00328718 - Completed
Asthma
- Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00396799 - Completed
Menopause
- Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
ClinicalTrials.gov Identifier: NCT00167921 - Completed
Atrophic Vaginitis
- A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.
ClinicalTrials.gov Identifier: NCT00500201 - Completed
Schizophrenia
- Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
ClinicalTrials.gov Identifier: NCT00550329 - Completed
Diabetes Mellitus, Non-Insulin-Dependent; Hyperglycemia
- Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
ClinicalTrials.gov Identifier: NCT00255528 - Completed
Hypertension
- A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
ClinicalTrials.gov Identifier: NCT00232154 - Completed
Sinusitis
- Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov Identifier: NCT00139230 - Completed
Squamous Cell Carcinoma; Carcinoma of Head/Neck
- An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
ClinicalTrials.gov Identifier: NCT00344383 - Completed
Metrorrhagia
- Micronutrients and Enteric Infections in African Children
ClinicalTrials.gov Identifier: NCT00156832 - Completed
Diarrhea
- The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
ClinicalTrials.gov Identifier: NCT00195741 - Completed
Migraine
- A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort
ClinicalTrials.gov Identifier: NCT00268827 - Completed
HIV-1; AIDS
- Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00343629 - Completed
Unspecified Adult Solid Tumor, Protocol Specific
- A Study Comparing the Efficacy of Long-Acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
ClinicalTrials.gov Identifier: NCT00236457 - Completed
Schizophrenia; Psychotic Disorders
- Follow-up Study of Patients Previously Treated with Pimecrolimus Tablets for Chronic Plaque-type Psoriasis
ClinicalTrials.gov Identifier: NCT00098189 - Completed
Psoriasis
- Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
ClinicalTrials.gov Identifier: NCT00387010 - Completed
Pain
- A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease
ClinicalTrials.gov Identifier: NCT00225810 - Completed
Crohn's Disease
- A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
ClinicalTrials.gov Identifier: NCT00249223 - Completed
Schizophrenia; Psychotic Disorders
- An Open-Label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-Dissolving Tablet Formulation of Risperdone
ClinicalTrials.gov Identifier: NCT00246272 - Completed
Schizophrenia
- Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00195767 - Completed
Bipolar I Disorder, Manic or Mixed
- Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
ClinicalTrials.gov Identifier: NCT00483652 - Completed
Multiple Sclerosis
- Evaluation of the Usefulness to Doctors of the Risperdal® Consta® Treatment Guidebook Over a Three-Month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-Acti
ClinicalTrials.gov Identifier: NCT00236548 - Completed
Psychotic Disorders; Schizophrenia
- Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
ClinicalTrials.gov Identifier: NCT00259987 - Completed
Adenocarcinoma
- Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141570 - Completed
Menopause
- Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00494962 - Completed
Alzheimer Disease
- Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
ClinicalTrials.gov Identifier: NCT00300378 - Completed
Depressive Disorder, Major
Resources
- Cipro (Drug Digest)
- Ciprofloxacin (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
